ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $3,074,000 | +33.1% | 343,900 | +30.9% | 0.19% | +2.1% |
| Q4 2016 | $2,309,000 | -61.0% | 262,700 | -70.1% | 0.19% | -60.4% |
| Q3 2016 | $5,925,000 | +335.7% | 877,800 | +129.7% | 0.48% | +278.0% |
| Q2 2016 | $1,360,000 | -16.3% | 382,200 | -30.6% | 0.13% | -22.6% |
| Q1 2016 | $1,625,000 | +1666.3% | 550,900 | +2415.5% | 0.16% | +1266.7% |
| Q4 2015 | $92,000 | -91.9% | 21,900 | -91.2% | 0.01% | -91.8% |
| Q3 2015 | $1,133,000 | +128.4% | 249,200 | +261.2% | 0.15% | +113.0% |
| Q2 2015 | $496,000 | – | 69,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |